Cargando…

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma

Microphthalmia-associated transcription factor (MiT) family translocation renal cell carcinoma harbors variable gene fusions involving either TFE3 or TFEB genes. Multiple 5′ fusion partners for TFE3 have been reported, including ASPSCR1, CLTC, DVL2, LUC7L3, KHSRP, PRCC, PARP14, NONO, SFPQ1, MED15, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Jianming, Cooper, Harry, Flieder, Douglas B., Talarchek, Jacqueline N., Al-Saleem, Tahseen, Uzzo, Robert G., Dulaimi, Essel, Patchefsky, Arthur S., Testa, Joseph R., Wei, Shuanzeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486435/ https://www.ncbi.nlm.nih.gov/pubmed/30622287 http://dx.doi.org/10.1038/s41379-018-0191-7

Ejemplares similares

MiT/TFE Family Renal Cell Carcinoma
por: Tang, Jinglong, et al.
Publicado: (2023)

Detecting MYB and MYBL1 Fusion Genes in Tracheobronchial Adenoid Cystic Carcinoma by Targeted RNA-Sequencing
por: Pei, Jianming, et al.
Publicado: (2019)

The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2020)

Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma
por: Dong, Xiang, et al.
Publicado: (2022)

Malignant renal epithelioid angiomyolipoma with TFE3 gene amplification mimicking renal carcinoma
por: Wang, Haili, et al.
Publicado: (2018)

A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion
por: Ye, Hong, et al.
Publicado: (2019)

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma
por: Sun, Guangxi, et al.
Publicado: (2021)

TFE3-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour
por: Aldera, Alessandro Pietro, et al.
Publicado: (2022)

PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue
por: Xiong, Lei, et al.
Publicado: (2017)

Clinical application of RNA sequencing in sarcoma diagnosis: An institutional experience
por: Pei, Jianming, et al.
Publicado: (2019)

Emerging roles and regulation of MiT/TFE transcriptional factors
por: Yang, Min, et al.
Publicado: (2018)

MiT/TFE Family of Transcription Factors: An Evolutionary Perspective
por: La Spina, Martina, et al.
Publicado: (2021)

TFE3-rearranged renal cell carcinoma with tumour thrombus in the ureter mimicking invasive transitional cell carcinoma
por: Chacko, Arman Z., et al.
Publicado: (2023)

TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms
por: Caliò, Anna, et al.
Publicado: (2022)

TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma
por: Lin, Junyi, et al.
Publicado: (2023)

Newly Designed Break-Apart and ASPL-TFE3 Dual-Fusion FISH Assay Are Useful in Diagnosing Xp11.2 Translocation Renal Cell Carcinoma and ASPL-TFE3 Renal Cell Carcinoma: A STARD-Compliant Article
por: Chen, Xiancheng, et al.
Publicado: (2015)

Dissection of tumor-intrinsic and tumor-extrinsic features of MiT/TFE translocation renal cell carcinoma via single-cell RNA sequencing
por: Konda, Prathyusha, et al.
Publicado: (2023)

Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Ling, Wenwu, et al.
Publicado: (2017)

Sunitinib treatment promotes metastasis of drug-resistant renal cell carcinoma via TFE3 signaling pathway
por: Li, Luchao, et al.
Publicado: (2021)

TFE3‐PD‐L1 axis is pivotal for sunitinib resistance in clear cell renal cell carcinoma
por: Guo, Xudong, et al.
Publicado: (2020)

Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis
por: Murakami, Sho, et al.
Publicado: (2023)

Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling
por: Calcagnì, Alessia, et al.
Publicado: (2016)

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
por: Simonaggio, Audrey, et al.
Publicado: (2022)

Emerging roles of TFE3 in metabolic regulation
por: Li, Xingyu, et al.
Publicado: (2023)

NRF-1 directly regulates TFE3 and promotes the proliferation of renal cancer cells
por: Zhuang, Wenyuan, et al.
Publicado: (2021)

Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
por: Wang, Zhen, et al.
Publicado: (2017)

Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma
por: Sun, Zhi-Jun, et al.
Publicado: (2016)

TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway
por: Fang, Yuan, et al.
Publicado: (2017)

The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review
por: Wei, Shuanzeng, et al.
Publicado: (2017)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis
por: Liu, Ning, et al.
Publicado: (2016)

Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents
por: Cao, Chuanzhen, et al.
Publicado: (2022)

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
por: Zhou, Jiale, et al.
Publicado: (2022)

TRIM28 represses renal cell carcinoma cell proliferation by inhibiting TFE3/KDM6A-regulated autophagy
por: Song, Tanjing, et al.
Publicado: (2023)

TFEB and TFE3 drive kidney cystogenesis and tumorigenesis
por: Di Malta, Chiara, et al.
Publicado: (2023)

MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5
por: Nezich, Catherine L., et al.
Publicado: (2015)

MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat
por: Annunziata, Ida, et al.
Publicado: (2019)

Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients
por: Agizamhan, Sezim, et al.
Publicado: (2018)

Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma
por: Cheng, Jun, et al.
Publicado: (2020)

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
por: Ge, Yan, et al.
Publicado: (2021)

Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report
por: Huang, Wenpeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r45c8uddcrn6oj7nlb5brh1t7e